398 related articles for article (PubMed ID: 15451760)
1. Racial differences in screening for prostate cancer in the elderly.
Gilligan T; Wang PS; Levin R; Kantoff PW; Avorn J
Arch Intern Med; 2004 Sep; 164(17):1858-64. PubMed ID: 15451760
[TBL] [Abstract][Full Text] [Related]
2. Prostate-specific antigen testing in black and white men: an analysis of medicare claims from 1991-1998.
Etzioni R; Berry KM; Legler JM; Shaw P
Urology; 2002 Feb; 59(2):251-5. PubMed ID: 11834397
[TBL] [Abstract][Full Text] [Related]
3. Racial differences in PSA screening interval and stage at diagnosis.
Carpenter WR; Howard DL; Taylor YJ; Ross LE; Wobker SE; Godley PA
Cancer Causes Control; 2010 Jul; 21(7):1071-80. PubMed ID: 20333462
[TBL] [Abstract][Full Text] [Related]
4. Prostate-specific antigen as predictor of prostate cancer in black men and white men.
Whittemore AS; Lele C; Friedman GD; Stamey T; Vogelman JH; Orentreich N
J Natl Cancer Inst; 1995 Mar; 87(5):354-60. PubMed ID: 7531773
[TBL] [Abstract][Full Text] [Related]
5. Reconstructing PSA testing patterns between black and white men in the US from Medicare claims and the National Health Interview Survey.
Mariotto AB; Etzioni R; Krapcho M; Feuer EJ
Cancer; 2007 May; 109(9):1877-86. PubMed ID: 17372918
[TBL] [Abstract][Full Text] [Related]
6. Racial inequities in the quality of surgical care among Medicare beneficiaries with localized prostate cancer.
Nyame YA; Holt SK; Etzioni RD; Gore JL
Cancer; 2023 May; 129(9):1402-1410. PubMed ID: 36776124
[TBL] [Abstract][Full Text] [Related]
7. Racial disparities in prostate cancer survival in a screened population: Reality versus artifact.
Kaur D; Ulloa-Pérez E; Gulati R; Etzioni R
Cancer; 2018 Apr; 124(8):1752-1759. PubMed ID: 29370459
[TBL] [Abstract][Full Text] [Related]
8. Racial Disparities in the Presentation, Early Definitive Surgical Treatment, and Mortality Among Men Diagnosed with Poorly Differentiated/Undifferentiated Non-metastatic Prostate Cancer in the USA.
Lediju O; Ikuemonisan J; Salami SS; Adejoro O
J Racial Ethn Health Disparities; 2019 Apr; 6(2):401-408. PubMed ID: 30506310
[TBL] [Abstract][Full Text] [Related]
9. Differences between African American and Caucasian men participating in a community-based prostate cancer screening program.
Barber KR; Shaw R; Folts M; Taylor DK; Ryan A; Hughes M; Scott V; Abbott RR
J Community Health; 1998 Dec; 23(6):441-51. PubMed ID: 9824793
[TBL] [Abstract][Full Text] [Related]
10. The Relationship of Baseline Prostate Specific Antigen and Risk of Future Prostate Cancer and Its Variance by Race.
Verges DP; Dani H; Sterling WA; Weedon J; Atallah W; Mehta K; Schreiber D; Weiss JP; Karanikolas NT
J Natl Med Assoc; 2017 Spring; 109(1):49-54. PubMed ID: 28259216
[TBL] [Abstract][Full Text] [Related]
11. Do racial disparities exist in the use of prostate cancer screening and detection tools in veterans?
Hudson MA; Luo S; Chrusciel T; Yan Y; Grubb RL; Carson K; Scherrer JF
Urol Oncol; 2014 Jan; 32(1):34.e9-18. PubMed ID: 23506962
[TBL] [Abstract][Full Text] [Related]
12. Disparities in treatment patterns and mortality in prostate cancer: Interaction between Black race and end-stage kidney disease.
Sarabu N; Dong W; Koroukian SM
Cancer Med; 2024 May; 13(10):e7027. PubMed ID: 38770622
[TBL] [Abstract][Full Text] [Related]
13. Use of lower prostate specific antigen cutoffs for prostate cancer screening in black and white men.
Smith DS; Carvalhal GF; Mager DE; Bullock AD; Catalona WJ
J Urol; 1998 Nov; 160(5):1734-8. PubMed ID: 9783942
[TBL] [Abstract][Full Text] [Related]
14. Literacy, race, and PSA level among low-income men newly diagnosed with prostate cancer.
Wolf MS; Knight SJ; Lyons EA; Durazo-Arvizu R; Pickard SA; Arseven A; Arozullah A; Colella K; Ray P; Bennett CL
Urology; 2006 Jul; 68(1):89-93. PubMed ID: 16844451
[TBL] [Abstract][Full Text] [Related]
15. Racial Differences in the Surgical Care of Medicare Beneficiaries With Localized Prostate Cancer.
Schmid M; Meyer CP; Reznor G; Choueiri TK; Hanske J; Sammon JD; Abdollah F; Chun FK; Kibel AS; Tucker-Seeley RD; Kantoff PW; Lipsitz SR; Menon M; Nguyen PL; Trinh QD
JAMA Oncol; 2016 Jan; 2(1):85-93. PubMed ID: 26502115
[TBL] [Abstract][Full Text] [Related]
16. Probability of an abnormal screening prostate-specific antigen result based on age, race, and prostate-specific antigen threshold.
Espaldon R; Kirby KA; Fung KZ; Hoffman RM; Powell AA; Freedland SJ; Walter LC
Urology; 2014 Mar; 83(3):599-605. PubMed ID: 24439009
[TBL] [Abstract][Full Text] [Related]
17. African-American men with prostate cancer have larger tumor volume than Caucasian men despite no difference in serum prostate specific antigen.
Fuletra JG; Kamenko A; Ramsey F; Eun DD; Reese AC
Can J Urol; 2018 Feb; 25(1):9193-9198. PubMed ID: 29524974
[TBL] [Abstract][Full Text] [Related]
18. Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men.
Moul JW; Sesterhenn IA; Connelly RR; Douglas T; Srivastava S; Mostofi FK; McLeod DG
JAMA; 1995 Oct; 274(16):1277-81. PubMed ID: 7563532
[TBL] [Abstract][Full Text] [Related]
19. Race/ethnicity and the intensity of medical monitoring under 'watchful waiting' for prostate cancer.
Shavers VL; Brown M; Klabunde CN; Potosky AL; Davis W; Moul J; Fahey A
Med Care; 2004 Mar; 42(3):239-50. PubMed ID: 15076823
[TBL] [Abstract][Full Text] [Related]
20. Prostate cancer screening: a racial dichotomy.
Calsoyas I; Stratton MS
Arch Intern Med; 2004 Sep; 164(17):1830-2. PubMed ID: 15451755
[No Abstract] [Full Text] [Related]
[Next] [New Search]
